A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest

S P Angus1, J R Nevins

  • 1Duke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, NC, USA.

Oncogene
|January 18, 2012
PubMed

Insights

Researchers identified MED13L as a crucial cofactor in the Rb/E2F pathway. This protein is essential for inhibiting cell proliferation and repressing genes that drive cell cycle progression in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Cycle Regulation

Background:

  • The Retinoblastoma (Rb)/E2F pathway is frequently disrupted in human cancers.
  • Key cofactors involved in Rb/E2F-mediated gene silencing are often lost or mutated in tumors.
  • Understanding these cofactors is critical for identifying novel therapeutic targets.

Purpose of the Study:

  • To identify novel cofactors essential for Rb/E2F-mediated inhibition of cell proliferation.
  • To investigate the role of the Mediator complex in Rb/E2F pathway function.

Main Methods:

  • Genome-wide short hairpin RNA (shRNA) screening was employed to identify essential genes.
  • Functional assays were performed to validate the role of identified cofactors in cell cycle control.

Main Results:

  • The screen identified components of the Mediator complex, a key transcriptional coactivator.
  • MED13L, a Mediator complex subunit, was found to be required for Rb/E2F-mediated cell growth inhibition.
  • MED13L is essential for the complete repression of cell cycle target genes.

Conclusions:

  • MED13L is a novel and critical cofactor for Rb/E2F pathway function.
  • MED13L plays a significant role in suppressing cell proliferation by regulating E2F target genes.
  • Targeting MED13L could represent a potential therapeutic strategy for cancers with deregulated Rb/E2F signaling.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...